Cancer risk in 348 French MSH2 or MLH1 gene carriers

被引：60
|
作者：
Parc, Y
Boisson, C
Thomas, G
Olschwang, S
机构：
[1] INSERM U434, F-75010 Paris, France
[2] INSERM U434, F-75012 Paris, France
来源：
JOURNAL OF MEDICAL GENETICS | 2003年 / 40卷 / 03期
关键词：
D O I：
10.1136/jmg.40.3.208
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：208 / 213
页数：6
相关论文
共 50 条
  • [1] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    [J]. HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [2] Risks of cancer for MLH1 and MSH2 mutation carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel
    Thibodeau, Stephen N.
    Casey, Graham
    Lindor, Noralane M.
    Gallinger, Steve
    Le Marchand, Loic
    Haile, Robert
    Newcomb, Polly
    Hopper, John L.
    Jenkins, Mark A.
    [J]. GENETIC EPIDEMIOLOGY, 2009, 33 (08) : 811 - 811
  • [3] MSH2 and MLH1 testing
    Grzegorz Kurzawski
    Janina Suchy
    Jan Lubiński
    [J]. Hereditary Cancer in Clinical Practice, 6
  • [4] MSH2 and MLH1 testing
    Kurzawski, Grzegorz
    Suchy, Janina
    Lubinski, Jan
    [J]. HEREDITARY CANCER IN CLINICAL PRACTICE, 2008, 6 (02) : 83 - 83
  • [5] Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
    Olschwang, Sylviane
    Yu, Kai
    Lasset, Christine
    Baert-Desurmont, Stephanie
    Buisine, Marie-Pierre
    Wang, Qing
    Hutter, Pierre
    Rouleau, Etienne
    Caron, Olivier
    Bourdon, Violaine
    Thomas, Gilles
    [J]. JOURNAL OF CANCER EPIDEMIOLOGY, 2009, 2009
  • [6] Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
    JG Dowty
    AK Win
    D Buchanan
    RJ Macinnis
    N Lindor
    SN Thibodeau
    G Casey
    S Gallinger
    L LeMarchand
    P Newcomb
    R Haile
    J Goldblatt
    S Parry
    FA Macrae
    JL Hopper
    MA Jenkins
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [7] MSH2 and MLH1 immunodetection and the prognosis of colon cancer
    Perrin, J
    Monges, G
    Parriaux, D
    Noguchi, T
    Giovannini, MH
    Giovannini, M
    Delpero, JR
    Birnbaum, D
    Monges, G
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (05) : 891 - 895
  • [8] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    [J]. CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105
  • [9] MLH1 and MSH2 expression in pterygia
    Schneider, Barbara G.
    Sahni, Deshdeepak
    Torres, Juan C.
    Dushku, Nicholas
    Reid, Ted W.
    [J]. CORNEA, 2007, 26 (04) : 468 - 472
  • [10] Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
    Dewkoemar Ramsoekh
    Anja Wagner
    Monique E van Leerdam
    Dennis Dooijes
    Carli MJ Tops
    Ewout W Steyerberg
    Ernst J Kuipers
    [J]. Hereditary Cancer in Clinical Practice, 7
12345